Bellus Health

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Bellus Health and other ETFs, options, and stocks.

About BLU

BELLUS Health, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of cough hypersensitivity and other hypersensitization disorders. Its product BLU-5937, is being developed for the treatment of chronic cough and chronic pruritus, or chronic itch. 

CEO
Roberto Bellini
CEORoberto Bellini
Employees
40
Employees40
Headquarters
Laval, Québec
HeadquartersLaval, Québec
Founded
1993
Founded1993
Employees
40
Employees40

BLU Key Statistics

Market cap
1.29B
Market cap1.29B
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
701.14K
Average volume701.14K
High today
$11.18
High today$11.18
Low today
$10.11
Low today$10.11
Open price
$10.69
Open price$10.69
Volume
618.42K
Volume618.42K
52 Week high
$12.69
52 Week high$12.69
52 Week low
$4.98
52 Week low$4.98

Analyst ratings

89%

of 9 ratings
Buy
88.9%
Hold
11.1%
Sell
0%

BLU Earnings

-$0.29
-$0.19
-$0.10
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 9, After Hours
ActualExpected Nov 9, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.